Drug Prices, Rebates, and Discounts

To the Editor The analysis of prescription drug net price growth by Dr Hernandez and colleagues has 2 methodological issues that affect the interpretation of results. First, the authors overestimated the increase in discounts provided by drug manufacturers to non-Medicaid payers and underestimated the increase in discounts to Medicaid. Second, their methodology for estimating the mean growth in prices and discounts cannot be linked to drug spending.
Source: JAMA - Category: General Medicine Source Type: research